PM360

OCTOBER 8, 2024

Developed to address ongoing provider burnout head-on, the new practice engagement solution reimagines how clinical care teams communicate and collaborate by providing a centralized hub for physicians and staff. PatientPoint plans to release the solution to other specialties within its network in 2025.For

Healthcare Provider 52

Healthcare Provider Pharma reps Pharma Rep Physicians 52

PM360

AUGUST 9, 2022

billion in 2025. Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension.

Prescription 105

Prescription Medical Patients Side effects 105

Clarify Health

JULY 13, 2020

By 2025, several new gene and cell therapies will be coming to market. Bhash cautioned, “if we do not start planning for their launches today, the investment pharma is making will not pay off.” Pharma real-world data The use of real-world data emerged as an area that is ripe for progress. It needs to start much earlier.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Impetus Digital

APRIL 24, 2023

A Vision for Medical Affairs In A Vision for Medical Affairs in 2025 –a recent McKinsey & Company report–the authors provided thought-provoking insights into the evolution of MA, mirroring what we have been hearing first-hand. This offers new opportunities to engage with stakeholders beyond just physicians.

Medical 52

Medical Education Physicians Healthcare 52

European Pharmaceutical Review

SEPTEMBER 29, 2023

When the Health Technology Assessment (HTA) Regulation , Regulation (EU) 2021/2282, enters into application in January 2025, this may well create additional delays, making the two-year deadline to launch even more challenging to respect.

Medicine 98

Medicine Medical Marketing Government 98

Contrarian Sales Techniques

FEBRUARY 25, 2023

The film features interviews with activists, physicians, and other experts who discuss the challenges and injustices that arose from the AIDS epidemic and the global response. Most pharma companies that distribute meds here in Malaysia did not manufacture their own product. The report also noted that the industry contributed RM5.5

Marketing 52

Marketing Distribution Medical Government 52

PM360

JUNE 16, 2023

This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives. Before the COVID-19 pandemic, diagnostic testing procedures involved patients visiting HCPs—namely their physician or nurse practitioner—for sample collection. It came back positive.

Marketing 52

Marketing Healthcare Healthcare Medical 52

Eversana Intouch

SEPTEMBER 27, 2024

Here are a few of the things we learned and some associated implications heading into 2025. And this is where the real conversations were happening – where pharma was actually asking oncologists about how trials should be conducted, soliciting their opinion and direction. EVERSANA was there with teams from across the U.S.

Patients 59

Patients Medical Healthcare Healthcare 59

Healthcare Success

NOVEMBER 7, 2022

According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. For example, pharma marketers can track and attribute increased prescriptions to specific ad campaigns. Your ads should be streaming, too.

Marketing 52

Marketing Media Healthcare Healthcare 52

Clarivate

OCTOBER 10, 2022

The biochemically recurrent treatment setting is heterogenous with no clear consensus on timing of hormonal therapy and duration of therapy among physicians. If approved, ERLEADA is likely to compete with Pfizer’s XTANDI®, which is also poised to enter this setting and may benefit from greater physician familiarity. Key ESMO findings.

Marketing 52

Marketing Safety Patients Competition 52

Evolve Your Success

NOVEMBER 28, 2023

I also started my career with Johnson & Johnson, being exposed to the Pharma side and then went to medical devices. This is all reported to their physician or their team of physicians. There are hundreds of billions of dollars spent in R&D and Pharma manufacturing to distribute drugs. We have run the gambit.

Medical 52

Medical Medical sales Sales Patients 52

Clarivate

AUGUST 20, 2024

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. Pharmas may choose to accept these discounts as a standard business cost or revise their strategies to mitigate the risk of being selected for price negotiations.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JULY 28, 2022

Still, the pharma industry is fighting hard to keep it off the table. Late last year, the Senate Finance Committee released draft legislation enabling Medicare negotiation for up to 10 drugs in 2025, 15 in 2026 and 2027, and 20 in 2028 and beyond. Pharma is a very profitable industry. The secretary of the U.S.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

Clarivate

OCTOBER 17, 2024

The Inflation Reduction Act instead allows the Centers for Medicare & Medicaid Services to begin negotiating Fair Maximum Prices for a growing list of Part D (outpatient) and Part B (physician-administered) drugs that represent the greatest cost to the federal government. Extending them would require Congressional action.

Healthcare 52

Healthcare Healthcare Government Insurance 52